Evidence map›Paper›PMID 38442272›Full record

ArticleThe Journal of experimental medicine2024

VEGF-C prophylaxis favors lymphatic drainage and modulates neuroinflammation in a stroke model.

Ligia Simoes Braga Boisserand, Luiz Henrique Geraldo, Jean Bouchart, Marie-Renee El Kamouh, Seyoung Lee, Basavaraju G Sanganahalli, Myriam Spajer, Shenqi Zhang, Sungwoon Lee, Maxime Parent and 24 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Single-cell RNA sequencing in stroke and traumatic brain injury: Current achievements, challenges and future perspectives on transcriptomic profiling.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. The cribriform plate: A dynamic central nervous system-immune hub.The Journal of experimental medicine · 2026
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors at 6 institutions in 4 countries.

Ligia Simoes Braga BoisserandDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-0058-2894
Luiz Henrique GeraldoCardiovascular Research Center, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-3318-4697
Jean BouchartDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-1761-0556
Marie-Renee El KamouhParis Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.ORCID 0000-0003-1918-0032
Seyoung LeeDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2824-6566
Basavaraju G SanganahalliDepartment of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.ORCID 0000-0002-0851-6621
Myriam SpajerParis Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.ORCID 0000-0001-7483-2983
Shenqi ZhangDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.ORCID 0000-0003-2939-6312
Sungwoon LeeDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-8019-8867
Maxime ParentDepartment of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.ORCID 0000-0003-3996-4029
Yuechuan XueDepartment of Anesthesiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0009-0045-2633
Mario SkaricaDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-2478-014X
Xiangyun YinDepartment of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-2879-6122
Justine GueganParis Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.
Kevin BoyéParis Cardiovascular Research Center, INSERM U970 , Paris, France.ORCID 0000-0002-5749-959X
Felipe Saceanu LeserParis Cardiovascular Research Center, INSERM U970 , Paris, France.ORCID 0000-0002-7499-2765
Laurent JacobParis Cardiovascular Research Center, INSERM U970 , Paris, France.ORCID 0000-0003-4767-0442
Mathilde PouletParis Cardiovascular Research Center, INSERM U970 , Paris, France.ORCID 0000-0002-2216-4132
Mingfeng LiDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-7959-6008
Xiaodan LiuDepartment of Anesthesiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-1500-9086
Sofia E VelazquezCardiovascular Research Center, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5954-3518
Ruchith SinghabahuParis Brain Institute, Université Pierre et Marie Curie Paris 06 UMRS1127, Sorbonne Université , Paris, France.ORCID 0009-0002-1242-1534
Mark E RobinsonCenter of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-2363-6047
Michael H AskenaseDepartment of Immunobiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5990-7289
Artem OsherovDepartment of Immunobiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-1595-4486
Nenad SestanDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0003-0966-9619
Jiangbing ZhouDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.ORCID 0000-0002-1201-5360
Kari AlitaloFaculty of Medicine, Wihuri Research Institute and Translational Cancer Biology Program, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-7331-0902
Eric SongDepartment of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5448-5865
Anne EichmannCardiovascular Research Center, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5563-210X
Lauren H SansingDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0002-6898-1680
Helene BenvenisteDepartment of Anesthesiology, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-2887-6667
Fahmeed HyderDepartment of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.ORCID 0000-0001-7822-4002
Jean-Leon ThomasDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0003-3397-0292
Yale University · USInserm · FRSorbonne Université · FRYale Cancer Center · USUniversidade Federal do Rio de Janeiro · BRUniversity of Helsinki · FI

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, David G. Schatz · 1985 to 2026
$14.4M
NeurophysiologicP30NS052519 · NINDS · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2007 to 2017
$6.7M
Energetics of Neuronal Populations by fMRIR01MH067528 · NIMH · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2002 to 2021
$5.9M
Neurovascular RegenerationR01EB016629 · NIBIB · YALE UNIVERSITY · PI HIRSCHI, KAREN KEMPER · 2014 to 2018
$4.8M
Extracellular pH mapping as therapeutic readout of drug delivery in glioblastomaR01EB023366 · NIBIB · YALE UNIVERSITY · PI HYDER, DEWAN SYED FAHMEED · 2017 to 2020
$2.5M
Role of meningeal lymphatic vasculature in neuroimmune communication developmentR01NS130057 · NINDS · YALE UNIVERSITY · PI Anne Christine Eichmann, AKIKO IWASAKI · 2023 to 2026
$2.1M
European Research CouncilNCATS NIH HHS UL1 TR001863NIAID NIH HHS T32 AI007019NIBIB NIH HHS R01 EB016629NIBIB NIH HHS R01EB016629-01NIBIB NIH HHS R01 EB023366NIH HHS P30 NS-052519NIMH NIH HHS R01 MH067528NINDS NIH HHS P30 NS052519NINDS NIH HHS R01 NS130057
6 · The paper itself

Abstract

Meningeal lymphatic vessels (MLVs) promote tissue clearance and immune surveillance in the central nervous system (CNS). Vascular endothelial growth factor-C (VEGF-C) regulates MLV development and maintenance and has therapeutic potential for treating neurological disorders. Herein, we investigated the effects of VEGF-C overexpression on brain fluid drainage and ischemic stroke outcomes in mice. Intracerebrospinal administration of an adeno-associated virus expressing mouse full-length VEGF-C (AAV-mVEGF-C) increased CSF drainage to the deep cervical lymph nodes (dCLNs) by enhancing lymphatic growth and upregulated neuroprotective signaling pathways identified by single nuclei RNA sequencing of brain cells. In a mouse model of ischemic stroke, AAV-mVEGF-C pretreatment reduced stroke injury and ameliorated motor performances in the subacute stage, associated with mitigated microglia-mediated inflammation and increased BDNF signaling in brain cells. Neuroprotective effects of VEGF-C were lost upon cauterization of the dCLN afferent lymphatics and not mimicked by acute post-stroke VEGF-C injection. We conclude that VEGF-C prophylaxis promotes multiple vascular, immune, and neural responses that culminate in a protection against neurological damage in acute ischemic stroke.

Indexed as

Ischemic StrokeStrokeAnimalsDrainageMiceNeuroinflammatory DiseasesVascular Endothelial Growth Factor CVascular Endothelial Growth Factor C

Identifiers

PMID38442272
PMCPMC10913814
OpenAlexW4392499983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.